A Safety and Efficacy Study of XERMELO® + First-line Chemotherapy in Patients With Advanced Biliary Tract Cancer
Clinical trial NCT03790111 · TERMINATED
Trial details
- NCT number
- NCT03790111
- Sponsor
- TerSera Therapeutics LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-13
- Primary completion
- 2022-01-13
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.